Olah, C., Shmorhun, O., Klamminger, G. G., Rawitzer, J., Sichward, L., Hadaschik, B., . . . Szarvas, T. Immunohistochemistry‐based molecular subtypes of urothelial carcinoma derive different survival benefit from platinum chemotherapy. Wiley.
Chicago Style (17th ed.) CitationOlah, Csilla, et al. Immunohistochemistry‐based Molecular Subtypes of Urothelial Carcinoma Derive Different Survival Benefit from Platinum Chemotherapy. Wiley.
MLA (9th ed.) CitationOlah, Csilla, et al. Immunohistochemistry‐based Molecular Subtypes of Urothelial Carcinoma Derive Different Survival Benefit from Platinum Chemotherapy. Wiley.
Warning: These citations may not always be 100% accurate.